Fosamprenavir Production Cost Reports

The report provides a detailed analysis essential for establishing a Fosamprenavir production plant. It encompasses all critical aspects necessary for Fosamprenavir production, including the cost of Fosamprenavir production, Fosamprenavir plant cost, Fosamprenavir production costs, and the overall Fosamprenavir production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Fosamprenavir production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Fosamprenavir is an antiretroviral medication primarily used in the treatment of HIV (Human Immunodeficiency Virus) infections. It is a prodrug of amprenavir, which means that it is converted into the active form of amprenavir in the body. It is mainly used as part of combination therapy to help control HIV replication and reduce the viral load in patients with HIV. It is often prescribed alongside other antiretroviral agents or with low-dose ritonavir to improve the effectiveness of treatment and prevent the development of drug resistance. It works by inhibiting the HIV protease enzyme, which is essential for the virus to replicate and spread. It can also be used in the treatment of HIV-infected children and adults, which helps to prevent the progression to AIDS. It is often used in managing HIV in pregnant women to reduce the risk of transmitting the virus to the baby. Moreover, Fosamprenavir is also sometimes used in research to study the effectiveness of combination therapies for HIV treatment.

The market for Fosamprenavir is primarily led by its application as an antiviral drug for the treatment of HIV in adults and children, which promotes its demand in the pharmaceutical industry. Its usage in combination with other antiretroviral medications, like ritonavir, to help control the viral load in HIV-positive patients significantly contributes to its demand in the medical and pharmaceutical industries.

Its usage in both adult and pediatric HIV treatment regimens further boosts its demand in the healthcare sector. The growing global prevalence of HIV and the need for more effective treatments, especially with the rise of drug-resistant strains, contribute to the increasing adoption of Fosamprenavir. Industrial Fosamprenavir procurement is affected by factors such as the cost and availability of raw materials, regulatory compliance, and the need to meet safety and efficacy standards. Furthermore, advancements in the production process, supplier reliability, sustainability practices, and efficient logistics also play a crucial role in shaping the procurement strategies for Fosamprenavir.

Raw Material for Fosamprenavir Production

According to the Fosamprenavir production plant project report, the major raw materials for Fosamprenavir production include L-Phenylalanine, Bromochloromethane, Isobutylamine, p-Nitrobenzene sulphonyl chloride, and (S)-Tetrahydrofuryl imidazole carboxylate.

Production Process of Fosamprenavir

The extensive Fosamprenavir production cost report consists of the following industrial production process:

1. Production from N,N-dibenzyl-L-phenylalaninal: The production process of Fosamprenavir Calcium begins with the preparation of N,N-dibenzyl-L-phenylalaninal by reducing L-phenylalanine to L-phenylalaninol, followed by N,N-dibenzylation and oxidation to the aldehyde. Then, the aldehyde is reacted with lithium shot and bromochloromethane to form a diastereomeric epoxide mixture, which is processed and recrystallised to form dibenzylaminochlorohydrin hydrochloride. Further, hydrogenolysis removes the protective groups, which gives a deprotected aminochlorohydrin. Further, this compound is converted to N-Boc-epoxide, which is cyclised and then converted to an amino alcohol. Then, treatment with p-nitrobenzene sulphonyl chloride and acid hydrolysis forms sulphonamide. Then, the carbamate is synthesised by reacting sulphonamide with (S)-tetrahydrofuryl imidazole carboxylate, and the sulphonamide is then treated with POCl3 and hydrolysed to form the phosphate intermediate. Finally, this intermediate undergoes hydrogenation, followed by conversion to Fosamprenavir Calcium salt as the final product.

Fosamprenavir is a phosphate ester prodrug of the antiretroviral protease inhibitor amprenavir used in the treatment of human immunodeficiency virus type 1 infection. It appears as a white to cream-colored solid and has a solubility of approximately 0.31 mg per mL in water at 25 degrees Celsius when in its calcium salt form. The molecular formula of the compound is C25H36N3O9PS, and its molecular mass is 585.61 g/mol. The compound is rapidly hydrolysed to its active metabolite amprenavir by cellular phosphatases in the gut epithelium during absorption, which allows for a reduced pill burden compared to amprenavir alone. The compound is marketed under the brand names Lexiva in the United States and Telzir in Europe. It should be used with caution in patients taking other medications, as extended administration of this antiretroviral may cause serious health problems such as gastrointestinal disturbances, including diarrhoea and nausea. It can also cause skin rashes, hypersensitivity reactions, lipid abnormalities, including elevated cholesterol and triglycerides, hepatotoxicity, and potential drug-drug interactions due to its effects on cytochrome P450 enzymes.